284 related articles for article (PubMed ID: 6498126)
1. Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration.
Ottoson UB; Carlstrom K; Damber JE; von Schoultz B
Br J Obstet Gynaecol; 1984 Nov; 91(11):1111-9. PubMed ID: 6498126
[TBL] [Abstract][Full Text] [Related]
2. Pituitary, ovarian and endometrial effects of progesterone released prematurely during the proliferative phase.
Shumin X; Johannisson E; Landgren BM; Diczfalusy E
Contraception; 1983 Feb; 27(2):177-93. PubMed ID: 6851555
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of deoxycorticosterone in women during the luteal phase of the ovarian cycle are not suppressed by dexamethasone treatment.
Parker CR; Rush AJ; MacDonald PC
J Steroid Biochem; 1983 Sep; 19(3):1313-7. PubMed ID: 6621037
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of 11-deoxycorticosterone in women during the menstrual cycle.
Parker CR; Winkel CA; Rush AJ; Porter JC; MacDonald PC
Obstet Gynecol; 1981 Jul; 58(1):26-30. PubMed ID: 6454093
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in corticosteroids in man.
Schöneshöfer M; Wagner GG
J Clin Endocrinol Metab; 1977 Oct; 45(4):814-7. PubMed ID: 914983
[TBL] [Abstract][Full Text] [Related]
7. The simultaneous assay of progesterone, 17-hydroxyprogesterone, and deoxycorticosterone in human plasma by competitive protein binding.
Honda M
Endocrinol Jpn; 1976 Jun; 23(3):259-64. PubMed ID: 991835
[TBL] [Abstract][Full Text] [Related]
8. Changes in peripheral hormone levels after therapeutic abortion.
Saunders DM; Kelso IM; Grudzinskas JG; Hughes GJ; Wilson GR
Eur J Obstet Gynecol Reprod Biol; 1978 Feb; 8(1):1-4. PubMed ID: 95666
[TBL] [Abstract][Full Text] [Related]
9. Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone.
Nahoul K; Dehennin L; Jondet M; Roger M
Maturitas; 1993 May; 16(3):185-202. PubMed ID: 8515718
[TBL] [Abstract][Full Text] [Related]
10. Normal values for a short-time ACTH intravenous and intramuscular stimulation test in women in the reproductive age.
Grunwald K; Rabe T; Urbancsek J; Runnebaum B; Vecsei P
Gynecol Endocrinol; 1990 Dec; 4(4):287-306. PubMed ID: 1964539
[TBL] [Abstract][Full Text] [Related]
11. The circadian pattern of melatonin and its positive relationship with progesterone in women.
Webley GE; Leidenberger F
J Clin Endocrinol Metab; 1986 Aug; 63(2):323-8. PubMed ID: 3722324
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery.
Sippell WG; Becker H; Versmold HT; Bidlingmaier F; Knorr D
J Clin Endocrinol Metab; 1978 Jun; 46(6):971-85. PubMed ID: 263476
[TBL] [Abstract][Full Text] [Related]
13. Production rate of deoxycorticosterone in women during the follicular and luteal phases of the ovarian cycle: the role of extraadrenal 21-hydroxylation of circulating progesterone in deoxycorticosterone production.
Winkel CA; Parker CR; Simpson ER; MacDonald PC
J Clin Endocrinol Metab; 1980 Dec; 51(6):1354-8. PubMed ID: 7440700
[TBL] [Abstract][Full Text] [Related]
14. Suppression and stimulation of mineralocorticoid hormones (MCH) in the simple virilizing form of congenital adrenal hyperplasia (CAH) evaluated by the quantitation in adrenal venous blood.
Wajchenberg BL; Biglieri EG; Okada H; Malerbi DA; Achando SS; Kater CE
J Steroid Biochem; 1983 Jul; 19(1B):655-61. PubMed ID: 6350722
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical function in prostatic cancer patients: effects of orchidectomy or different modes of estrogen treatment on basal steroid levels and on the response to exogenous adrenocorticotropic hormone.
Carlström K; Stege R
Urol Int; 1990; 45(3):160-3. PubMed ID: 2161578
[TBL] [Abstract][Full Text] [Related]
16. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
17. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
[TBL] [Abstract][Full Text] [Related]
18. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
Andreassen B; Huth J; Tyson JE
Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
[TBL] [Abstract][Full Text] [Related]
19. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
